Daily non-political popular news in brief.

New antibiotic drug combo to speed up treatment of tuberculosis

A team of tuberculosis experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.

Read more »

Keywords: antibiotic, drug, combo, speed, treatment, tuberculosis, tuberculosi

« Previous | Next »

Similar news on "New antibiotic drug combo to speed up treatment of tuberculosis":

1. Radioactive 'understudy' may aid medical imaging, drug development
   01-09-2008 · EurekAlert!
   Broadway stars have understudies. Now, an increasingly popular radioactive isotope has its own stand-in. Developed in part by researchers at the National Institute of Standards and Technology, the substance might ultimately improve medical imaging, speed up clinical trials of many drugs and facilitate efforts to develop more individualized medical treatment.
   Similar news · Read more »
   
2. New research may overturn conventional wisdom on drug-resistant tuberculosis
   02-20-2007 · EurekAlert!
   A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance. If confirmed in future studies the research, in the March 15 issue of the Journal of Infectious Diseases, may drive a major shift in strategy for controlling TB.
   Similar news · Read more »
   
3. Older antibiotic gains new respect as potent treatment for tuberculosis
   12-17-2007 · EurekAlert!
   It has no current market, not even a prescription price. Its makers stopped commercial production years ago, because demand was so low. But an antibiotic long abandoned as a weak, low-dose treatment for tuberculosis may have found renewed purpose, this time as a potent, high-dose fighter against the most common and actively contagious form of the lung disease.
   Similar news · Read more »
   
4. Extensively drug-resistant tuberculosis is emerging threat
   10-27-2006 · EurekAlert!
   Strains of tuberculosis (TB) that are resistant to both first-line and second-line drugs could threaten the success of not only tuberculosis programs, but also HIV treatment programs worldwide, according to an article published online this week in the Lancet.
   Similar news · Read more »
   
5. American Thoracic Society publishes new statement on hepatotoxicity of antituberculosis therapy
   11-07-2006 · EurekAlert!
   The American Thoracic Society (ATS) has published a new statement on the pathogenesis, prevention and treatment of liver damage caused by anti-tuberculosis (TB) medications. The statement, which appeared in the October 15 issue of the American Journal of Respiratory and Critical Care Medicine, gives a review of current national and international literature on drug-induced liver injury (DILI) or hepatotoxicity, a potential side effect of more than 700 drugs approved for use in the United States.
   Similar news · Read more »
   
6. Improved understanding of new malaria treatment
   11-27-2006 · EurekAlert!
   The following articles are in the upcoming issue of the Journal of Neuroscience: Improved understanding of new malaria treatment; and Potential new drug in war against tuberculosis.
   Similar news · Read more »
   
7. Radiation and drug combo helps boost efficacy of lung cancer treatment
   09-01-2007 · EurekAlert!
   Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
   Similar news · Read more »
   
8. Radiation and drug combo helps boost efficacy of lung-cancer treatment
   09-04-2007 · UT Southwestern Medical Center
   Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
   Similar news · Read more »
   
9. Lab-on-a-chip could speed up treatment of drug-resistant pneumonia
   11-14-2006 · EurekAlert!
   A new lab-on-a-chip can identify single bacterial cells for the most common cases of drug-resistant pneumonia, cutting down the wait from days to hours for identifying the particular strain and treating it.
   Similar news · Read more »
   
10. New study finds antibiotic vancomycin may trigger dangerously low platelet count
    02-28-2007 · EurekAlert!
    The antibiotic vancomycin often used in intensive care units is considered the drug of choice for the treatment of staphylococci (staph) infections that are resistant to most other antibiotics.
    Similar news · Read more »